The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 22, 2023
Filed:
Dec. 13, 2019
Applicants:
Orphelia Pharma, Paris, FR;
Institut Gustave Roussy, Villejuif, FR;
Inventors:
Maxime Annereau, Vincennes, FR;
Jérémy Bastid, Tassin La Demi Lune, FR;
Hugues Bienayme, Saint-Symphorien-d'Ozon, FR;
François Lemare, Suresnes, FR;
Mathieu Schmitt, Paris, FR;
Lionel Tortolano, Paris, FR;
Samuel Abbou, Paris, FR;
Assignees:
Orphelia Pharma, Paris, FR;
Institut Gustave Roussy, Villejuif, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/495 (2006.01); A61K 9/08 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/495 (2013.01); A61K 9/08 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01); A61K 9/0053 (2013.01);
Abstract
A pharmaceutical liquid suspension comprising: temozolomide or a salt thereof; at least one agent controlling the solid state of temozolomide in suspension; a pharmaceutically acceptable liquid vehicle; and optionally at least one acid in a quantity so that the pH of the composition is below 5; or a powder blend for reconstituting said suspension, is provided.